Latest news with #Zyn
Yahoo
2 days ago
- Business
- Yahoo
Philip Morris International Shares Tumble: Time to Run for the Hills or Buy the Dip?
Key Points Philip Morris International shares fell after the company's second-quarter report, despite strong earnings and increased EPS guidance. The company is expecting to see cigarette sales volumes decline in the second half. The real story at Philip Morris is about the continued strong growth of Zyn and Iqos. 10 stocks we like better than Philip Morris International › Philip Morris International (NYSE: PM) stock has had a strong 2025 so far, but the shares pulled back after the company reported its second-quarter results. That dip left the stock up about 36% on the year, as of this writing. Is the recent slide a buying opportunity or should investors be running for the hills? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Strong volume growth The Zyn brand remains the driving force behind Philip Morris' robust sales growth. Shipments of the popular nicotine pouches jumped 40% in the U.S. to 190 million cans in Q2, while retail sales volumes (offtake) grew by 26% in the quarter and by 36% in June. Outside of the U.S. and Nordic countries, Zyn shipments more than doubled, and it is now available in 44 markets. Overall oral product shipments climbed 23.8% on a pouch basis. The company said Zyn restocking in the U.S. is now effectively complete. It continues to expect U.S. Zyn shipments to be between 800 million and 840 million cans for the year. Image source: Getty Images The rest of Philip Morris' smokeless portfolio also performed well. Sales volumes of its heated tobacco units (HTUs), including the Iqos system, jumped nearly 9.2% to 38.8 billion units. The company said in-market sales (to end users) jumped 11.4%. Iqos continues to perform well in Japan and Europe and is seeing strong growth in other major cities outside its two main markets. Philip Morris also once again saw shipment growth more than double for its e-vapor product, Veev, driven by pod growth in Europe. Veev is now in 42 markets and holds the No. 1 market share in six European markets. Traditional cigarette volumes, meanwhile, fell by 1.5% to 155.2 billion units. Segment organic revenue, however, grew 2% to $6 billion, and gross profits for the category climbed 5% to $4 billion, as the company's price hikes more than compensated for those volume declines. Overall, organic revenue, which excludes currency effects, acquisitions, and dispositions, rose 6.8% year over year to $10.1 billion. Adjusted earnings per share (EPS) climbed 20% to $1.91. Oral Products (Zyn) HTUs Cigarettes Smoke-Free Total Volume growth 23.8% 9.2% (1.5%) N/A 1.2% Organic revenue growth N/A N/A 2% 14.5% 6.8% HTUs = heated tobacco units. Management maintained its full-year guidance for organic revenue while upping its adjusted EPS forecast. It continues to expect strong results from both Zyn and Iqos, but expects a 3% to 4% decline in traditional cigarette volumes due to ongoing issues in Turkey and Indonesia. The headwind in Turkey is related to supply chain issues following a change in regulatory requirements, while in Indonesia, it's battling to keep market share in the face of growing sales of illicit cigarettes. However, it's still expecting solid gross profit growth from its combustible tobacco business due to its pricing power and cost efficiencies. Metric Prior Guidance Updated Guidance Organic revenue growth 6% to 8% 6% to 8% Adjusted EPS $7.01 to $7.14 $7.43 to $7.56 Adjusted EPS growth* 10.5% to 12.5% $7.33 to $7.46 Volume growth 2% 1% Data source: Philip Morris International. *Adjusted EPS growth excludes currency exchange impacts. EPS = earnings per share. Should investors buy the dip? While investors may have been disappointed by Philip Morris' forecast for steeper declines in cigarette sales volumes in the second half, about half of that is due to a temporary issue around its Turkish supply chain. Meanwhile, the big reason to own the stock is its smoke-free portfolio, led by Zyn and Iqos. Both products continue to demonstrate strong growth and have better unit economics than Philip Morris' traditional cigarette business. It's also expanding these products to new markets, with early signs of success. Importantly, the company is hoping that the FDA will approve the Iqos Iluma for sale in the U.S. later this year, which would set it up to enter this market now that it has reacquired its U.S. rights from Altria. From a valuation perspective, the stock got cheaper when management raised its EPS guidance and its share price fell. The stock now trades at a forward price-to-earnings (P/E) ratio of under 22, based on the analyst consensus for 2025, with a PEG (price/earnings-to-growth) ratio of under 0.35. Stocks with positive PEG ratios below 1 are generally viewed as undervalued. While at the current share price, Philip Morris' dividend has a nice 3.3% forward yield, that's not as high a yield as other tobacco stocks. However, what it lacks in yield, it makes up for by being a unique growth stock in a defensive industry. This is a stock you'll want to own over the long haul, and the dip in the stock price offers a nice buying opportunity. Should you invest $1,000 in Philip Morris International right now? Before you buy stock in Philip Morris International, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Philip Morris International wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Geoffrey Seiler has positions in Philip Morris International. The Motley Fool recommends Philip Morris International. The Motley Fool has a disclosure policy.
Associated Press
5 days ago
- Health
- Associated Press
PKJ Coaching Launches Groundbreaking Dopamine Recovery Program to Help ADHD Adults Taper Off Stimulants Without Losing Their Edge
Miami Beach, FL - July 25, 2025 - In a bold step away from conventional ADHD treatment models, Pen King Jr. — a former elite ski racer turned ADHD recovery coach — has launched PKJ Coaching, a revolutionary platform designed to help adults taper off prescription stimulants such as Adderall and Vyvanse while reclaiming their focus, energy, and emotional clarity — all without medication. With stimulant prescriptions and over-the-counter dopamine enhancers like nicotine pouches, caffeine, and SSRIs at an all-time high, many high-functioning adults are facing a hidden crisis: burnout, emotional numbness, and growing dependency on external chemicals for basic mental performance. PKJ Coaching aims to offer a radical new path — helping adults reset their nervous systems and rebuild dopamine naturally through neuroscience-backed coaching and personalized habit design. 'We've normalized dependency. People are taught that they can't function without a pill, a pouch, or a prescription,' says Pen King Jr., founder of PKJ Coaching. 'But the truth is, we can retrain the brain. We can rebuild dopamine resilience. That's what this program is all about.' A Personal Mission That Sparked a Movement After spending 17 years on prescription stimulants for ADHD, King experienced the same crash that many high performers face in silence — emotional burnout, loss of motivation, and a growing inability to function without medication. 'There came a point where I wasn't sure who I was without the pills,' says King. 'So I made a choice: quit cold turkey and start rebuilding. I spent years learning what the brain truly needs to regulate itself — and then I turned it into a method that others can use.' That method is now available through PKJ Coaching, a dopamine-first, drug-free coaching platform helping adults recover motivation, emotional clarity, and natural focus — without relying on medication. What Makes PKJ Coaching Different? Unlike general productivity or mindset coaching programs, PKJ Coaching is specifically designed for adults tapering off Adderall, Vyvanse, Zyn, SSRIs, and other common dopamine-altering substances. Key Features Include: 'This isn't just about productivity. It's about rewiring your entire nervous system to function without needing an external fix,' explains King. 'We're not anti-medication — we're anti-dependency.' Why the Anti-Adderall Era is Gaining Traction The rise in adult ADHD diagnoses, coupled with social trends around microdosing and stimulant use, has led to what King calls a 'dopamine dysregulation epidemic.' While ADHD is a real and serious condition, many adults are misdiagnosed or overmedicated, only to find themselves stuck in a perform-crash cycle: productive during the day but emotionally hollow at night. PKJ Coaching challenges this dynamic by offering an alternative to long-term stimulant use — one that helps clients achieve clarity, motivation, and emotional stability naturally. 'We're helping people wake up motivated and go to sleep peaceful — without pills. That's the future of ADHD care,' says King. Who PKJ Coaching is Built For PKJ Coaching is tailored for high-functioning adults who are seeking a smarter, sustainable way to manage their focus and energy without depending on medications. The program is ideal for: Whether you're a startup founder juggling too many tabs, an artist feeling creatively stuck, or a parent looking to break free from prescription dependency — PKJ Coaching offers a guided path toward mental resilience and renewed identity. Free Strategy Session Now Available Prospective clients can now book a free 1-on-1 strategy session with Pen King Jr., to evaluate their goals, current use of medication and their state of readiness to begin a structured tapering and recovery protocol. Visit to learn more or to book a consultation. About PKJ Coaching PKJ Coaching is a dopamine-first coaching platform founded by ADHD recovery coach Pen King Jr. The program combines stimulant tapering protocols, neuro-habit rewiring, and emotional regulation tools to help adults rebuild motivation and focus naturally — without relying on prescription drugs. Built for creatives, leaders, parents, and professionals, PKJ Coaching provides a personalized, science-backed path to mental clarity and resilience. Media Contact: Pen King Jr. Founder, PKJ Coaching [email protected] Media Contact Company Name: PKJ Coaching Contact Person: Pen King Jr. Email: Send Email City: Miami Beach State: Florida Country: United States Website: Source: AIO Newswire
Business Wire
6 days ago
- Health
- Business Wire
2025 Nicotine Pouch and Oral Nicotine Report: U.S. Nicotine Pouch Market Surges 40% as Smokers Seek Smoke-Free Alternatives
WASHINGTON--(BUSINESS WIRE)-- in collaboration with has released the 2025 Nicotine Pouch and Oral Nicotine Report, revealing a remarkable 40% year-over-year growth in the U.S. nicotine pouch market during 2024. This surge was driven by robust market momentum and an influx of new adult customers turning to the convenience of online retail. The report draws on comprehensive insights from a consumer survey that was conducted between February and April 2025, featuring responses from 1,670 adult nicotine pouch consumers, as well as 2024 purchasing data from over 234,000 customers across both ecommerce platforms. The findings highlight a compelling trend: adult consumers are increasingly turning to smoke-free and tobacco-leaf-free alternatives like nicotine pouches primarily to change from traditional combustible tobacco products. Nearly half of all adult pouch users surveyed – 42% – started using nicotine pouches to quit smoking. Furthermore, one in three respondents (32%) state they used the product as a way to quit chewing tobacco. Additionally, 92% of former smokers reported perceived improvements in their well-being after transitioning to nicotine pouches. 'Adult nicotine and tobacco consumers are increasingly seeking modern, tobacco leaf-free and smoke-free nicotine alternatives—driving rapid growth in demand for nicotine pouches,' said Laura Leigh Oyler, Vice President, Regulatory Affairs at 'The 2025 report not only highlights evolving consumer behavior but also emphasizes the broader influence of innovation and regulatory developments on the category. As responsible and compliant retailers, we are committed to leading by example—shedding light on key market shifts that will impact access and product range for adult nicotine users pursuing a smoke-free lifestyle.' Key findings from the 2025 report include: Men are the most likely consumers: Almost nine out of ten adult online buyers (88%) of nicotine pouches in the U.S. are men. Almost nine out of ten adult online buyers (88%) of nicotine pouches in the U.S. are men. Zyn holds the top spot—barely: Zyn maintained its position as market leader in 2024, despite facing product shortages in the second half of the year, while brands like On! and Rogue capitalized and gained ground in 2024. Zyn maintained its position as market leader in 2024, despite facing product shortages in the second half of the year, while brands like On! and Rogue capitalized and gained ground in 2024. Online retail offers strong age verification: The typical adult nicotine pouch user in our survey began using pouches at age 44. A full 96% of pouch users reported they started to use the product when they were 18 or older, and 88% reported being 24 or older. A small share of pouch users (4%) reported they used the product before the age of 18. Although many survey respondents perceive online channels as being of major risk for underage access, the survey also makes it clear that traditional retail stores are by far the number one source of nicotine pouches for underage users. 56% of those who reported using nicotine pouches as minors say they acquired the product from local stores, and 22 percent from supermarket chains, compared to 4% who bought them online. The typical adult nicotine pouch user in our survey began using pouches at age 44. A full 96% of pouch users reported they started to use the product when they were 18 or older, and 88% reported being 24 or older. A small share of pouch users (4%) reported they used the product before the age of 18. Although many survey respondents perceive online channels as being of major risk for underage access, the survey also makes it clear that traditional retail stores are by far the number one source of nicotine pouches for underage users. 56% of those who reported using nicotine pouches as minors say they acquired the product from local stores, and 22 percent from supermarket chains, compared to 4% who bought them online. Regulatory clarity emerging: In a milestone decision, the FDA authorized marketing of 20 ZYN products in January 2025, signaling a new era of regulatory transparency for the category. The 2025 report disrupts common public assumptions about youth access to nicotine products, revealing a stark contrast between perception and reality. While some survey respondents view online sales as a major risk, the data tells a different story: traditional retail stores remain the primary source of underage access. Among respondents who used nicotine pouches as minors, 56% said they obtained them from local retail stores and 22% from supermarket chains—compared to 4% who reported purchasing online. Insights from the survey also show that 98% of US consumers were age-verified when purchasing nicotine pouches online, well above the 75% reported in physical retail stores. While industry leaders like and have helped establish strong verification standards, the remaining 2% likely reflect purchases made through other, less compliant online retailers. This underscores the importance of consistent enforcement and accountability across all sales channels. 'Empowering adult consumers with access to a range of smoke-free alternatives is essential to driving meaningful change,' added Oyler. 'This report reinforces the growing role of nicotine pouches in supporting tobacco harm reduction and highlights the need for continued focus on responsible retail practices and informed adult use.' The 2025 Nicotine Pouch and Oral Nicotine Report is available for download here. About Nicokick Nicokick is a leading online retailer in the U.S. specializing in nicotine pouches. With a diverse inventory of over 200 unique products, the platform offers a wide selection of popular and emerging brands that provide adult consumers with modern oral smoke-free and tobacco leaf-free alternatives to cigarettes and other traditional tobacco products. As a responsible and compliant retailer, Nicokick is committed to a strict age and identity verification process, with all products delivered directly to adult consumers. For more information, visit About Northerner Established in 1998, Northerner has grown to become one of the largest global online retailers of nicotine pouches. Northerner's US platform has an inventory of over 200 tobacco-leaf-free nicotine products that help adult consumers transition from cigarettes. With a strong commitment to youth access prevention, Northerner's products are securely delivered to adult consumers, ensuring compliance with a rigorous age verification process. For more information, visit
Wall Street Journal
22-07-2025
- Business
- Wall Street Journal
Philip Morris Shares Drop 7% on Lower-Than-Expected Volumes of Zyn Pouches
Philip Morris International's PM -7.09%decrease; red down pointing triangle shares fell nearly 7% as its quarterly revenue missed forecasts and it shipped fewer tins of its popular nicotine pouch Zyn than expected. The tobacco company also said that its total product shipments may be lower in the second half of this year compared with last year, weighed down by an expected 2% decline in cigarette volume for the full year.
Wall Street Journal
22-07-2025
- Business
- Wall Street Journal
Philip Morris 2Q EPS Tops Views, Company Boosts 2025 EPS Projection
Philip Morris International's PM 0.98%increase; green up pointing triangle second-quarter earnings surpassed Wall Street expectations on higher revenue and the tobacco giant boosted its projection for 2025 growth, with fortunes lifted by the burgeoning popularity of its Zyn oral nicotine pouches. The tobacco company, which sells cigarettes such as Marlboro, Parliament in overseas markets and smokeless tobacco such as Zyn worldwide, logged second-quarter earnings of $1.95 a share.
